- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/04 - Immunostimulants
Patent holdings for IPC class A61P 37/04
Total number of patents in this class: 5257
10-year publication summary
|
240
|
263
|
233
|
298
|
355
|
368
|
482
|
528
|
448
|
142
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1701 |
75 |
| The Trustees of the University of Pennsylvania | 4122 |
57 |
| National Research Council of Canada | 1545 |
42 |
| The Regents of the University of California | 18943 |
38 |
| Osaka University | 3143 |
38 |
| The University of British Columbia | 1432 |
38 |
| Bristol-myers Squibb Company | 5080 |
35 |
| Immatics Biotechnologies GmbH | 1144 |
35 |
| University of Saskatchewan | 450 |
34 |
| The Governors of the University of Alberta | 869 |
33 |
| Toray Industries, Inc. | 6652 |
32 |
| Nestec S.A. | 2777 |
29 |
| Medicago Inc. | 203 |
27 |
| Variation Biotechnologies, Inc. | 75 |
26 |
| Pfizer Inc. | 3322 |
25 |
| Inovio Pharmaceuticals, Inc. | 308 |
25 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
25 |
| Riken | 1669 |
25 |
| Merck Sharp & Dohme LLC | 3689 |
25 |
| Oncotherapy Science, Inc. | 302 |
23 |
| Other owners | 4570 |